Literature DB >> 8623490

A randomized, double-blind, placebo-controlled study of the safety, tolerance, and preliminary pharmacokinetics of ascending single doses of orally administered sirolimus (rapamycin) in stable renal transplant recipients.

E M Johnson1, J Zimmerman, K Duderstadt, J Chambers, A L Sorenson, D K Granger, P S Almond, J p Fryer, J R Leventhal, J Scarola, A J Matas, D M Canafax.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8623490

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  6 in total

1.  Population pharmacokinetics of sirolimus in de novo Chinese adult renal transplant patients.

Authors:  Zheng Jiao; Xiao-jin Shi; Zhong-dong Li; Ming-kang Zhong
Journal:  Br J Clin Pharmacol       Date:  2009-07       Impact factor: 4.335

Review 2.  Immunosuppressive drugs in paediatric liver transplantation.

Authors:  I D van Mourik; D A Kelly
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 3.  Clinical pharmacokinetics of sirolimus.

Authors:  K Mahalati; B D Kahan
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

4.  Gonadal dysfunction and infertility in kidney transplant patients receiving sirolimus.

Authors:  Yousef Boobes; Bassam Bernieh; Hussein Saadi; M Raafat Al Hakim; Samra Abouchacra
Journal:  Int Urol Nephrol       Date:  2009-09-23       Impact factor: 2.370

5.  Acute sirolimus overdose: a multicenter case series.

Authors:  Alessandro Ceschi; Elja Heistermann; Sonja Gros; Cornelia Reichert; Hugo Kupferschmidt; Nicholas R Banner; Stephan Krähenbühl; Anne B Taegtmeyer
Journal:  PLoS One       Date:  2015-05-28       Impact factor: 3.240

6.  Long-term mTOR inhibitors administration evokes altered calcium homeostasis and platelet dysfunction in kidney transplant patients.

Authors:  Esther López; Alejandro Berna-Erro; Nuria Bermejo; José María Brull; Rocío Martinez; Guadalupe Garcia Pino; Raul Alvarado; Ginés María Salido; Juan Antonio Rosado; Juan José Cubero; Pedro Cosme Redondo
Journal:  J Cell Mol Med       Date:  2013-04-12       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.